Buy Forty Seven Inc Stock | FTSV Stock Price & Latest News | Public
FTSV

Forty Seven Inc

$0.00 (0.00%)Today

    About FTSV

    Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways based on technology licensed from Stanford University. Forty Seven's lead program, 5F9, is a monoclonal antibody against the CD47 receptor...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.25
    -0.5
    -0.75
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.74

    Actual EPS
    Q4 2020

    Stats

    Market Cap$4,59B
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$95.52
    1 Year Low$5.53
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app